anti-HIV antibodies

anti-HIV antibodies

antibodies formed a few weeks after exposure to human immunodeficiency virus (HIV); the person has seroconverted, and is termed 'HIV-positive'
Mentioned in ?
References in periodicals archive ?
Early detection of anti-HIV antibodies as a marker of HIV and accurate diagnosis of the infection are crucial factors for timely identification of affected patients, prevention strategies, and control of the disease.
While the titers of anti-HCV antibodies in the serum and perilymph were of similar magnitude, there were almost 16 times more anti-HIV antibodies in the serum than in the perilymph.
The US study detected anti-HIV antibodies by enzyme-linked immunosorbent assay (ELISA) testing in 14% of uninfected infants > 18 months of age, with the median time to seroreversion occurring at > 13 months of age.
Our study shows the seroprevalence for anti-HIV antibodies to be 1.
Advances in isolating antibodies from HIV-infected individuals have allowed for the discovery of a large number of new, broadly neutralizing anti-HIV antibodies directed against the host receptor (CD4) binding site--a functional site at the surface of the virus that allows for cell entry and infection.
The serum was tested for Anti-HIV antibodies using ELISA test(Biotest anti-HIV TETRA ELISA) as the screening assay and test was performed and interpreted as per the manufacturer's instructions.
Current advances in isolating antibodies from HIV-infected individuals have allowed for the discovery of a large number of new, broadly neutralizing anti-HIV antibodies directed against the host receptor (CD4) binding site -- a functional site on the surface of the virus that allows for cell entry and infection.
Researchers at Rockefeller University and colleagues have now made two fundamental discoveries about the so-called broadly neutralizing anti-HIV antibodies, which effectively keep the virus at bay.
All of them were tested negative for both hepatitis B surface antigen (HbsAg) and anti-HIV antibodies.
In the US, the presence of anti-HIV antibodies in the blood of someone who has the constellation of symptoms of AIDS, such as diarrhea, dementia, Kaposi's sarcoma, pneumonia, and tuberculosis, would be determined to have AIDS.
Their white blood cells flood the body with anti-HIV antibodies, although how this process works is still unclear.
Tokyo, Japan, July 19, 2006 - (JCN) - Trans Genic, a biotech company specializing in genome function research, and the Kumamoto Techno Industrial foundation have concluded an exclusive license agreement on anti-HIV antibodies PCT/JP2004/003046.